How Much Did OneThree Biotech Raise?
Funding & Key Investors

OneThree Biotech has successfully secured a significant capital injection, bringing its total funding to $2.5M. This latest infusion of $2.5M marks a pivotal moment for the organization as it transitions from foundational research to broader enterprise-level deployment. By leveraging advanced computational frameworks, the company continues to attract high-profile backing to accelerate its mission of transforming the drug discovery landscape through rigorous, biology-driven artificial intelligence.

What is OneThree Biotech?

OneThree Biotech
Business ServicesResearch & DevelopmentSoftware Testing

OneThree Biotech operates at the intersection of systems biology and machine learning, providing a clinically validated platform that deciphers complex drug-target-disease relationships. By integrating disparate chemical, biological, and clinical datasets, the company enables pharmaceutical partners to generate actionable hypotheses with unprecedented speed. This proprietary technology has been rigorously tested, evidenced by over 20 peer-reviewed publications and successful outcomes in early-stage development pipelines. The firm's market position is defined by its ability to reduce the inherent risks of drug development, offering a sophisticated computational alternative to traditional, trial-and-error laboratory methods.

How much funding has OneThree Biotech raised?

OneThree Biotech has raised a total of $2.5M across 1 funding round:

2020

Angel/Seed

$2.5M

Angel/Seed (2020): $2.5M with participation from Primary Venture Partners and Meridian Street Capital

Key Investors in OneThree Biotech

Primary Venture Partners

A venture capital firm focused on supporting early-stage companies with high growth potential through strategic mentorship and capital allocation.

Meridian Street Capital

A closely held investment fund that partners with entrepreneurs to foster business development and long-term operational growth.

What's next for OneThree Biotech?

With this major strategic investment, OneThree Biotech is positioned to scale its computational infrastructure and expand its portfolio of industry partnerships. The company is expected to focus on deepening its clinical validation efforts, potentially moving into more complex therapeutic areas where its AI platform can provide the most significant competitive advantage. As the firm matures, the focus will likely shift toward long-term commercialization strategies and the integration of its predictive models into global pharmaceutical R&D workflows, solidifying its role as a critical enabler of modern precision medicine.

See full OneThree Biotech company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesField Service ManagementDocument Management
Business ServicesCommercial Printing
Business ServicesResearch & Development
Business ServicesHuman Resources Management Systems (HRMS)

Frequently Asked Questions Regarding OneThree Biotech Financial Insights

What are the most recent funding rounds that OneThree Biotech has completed, and what were the funding rounds?
OneThree Biotech has recently completed 1 funding rounds: Angel/Seed on Mar 26, 2020.
What is the total amount of funding OneThree Biotech has raised to date?
OneThree Biotech has raised a total of $2.5M in funding to date.
How many funding rounds has OneThree Biotech completed?
OneThree Biotech has completed 1 funding rounds.
How much funding did OneThree Biotech raise in its most recent funding round?
OneThree Biotech raised $2.5M in its most recent funding round.
Who are the lead investors in OneThree Biotech's latest funding round?
The lead investor in OneThree Biotech's latest funding round was Primary Venture Partners. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in OneThree Biotech's history?
The largest funding round in OneThree Biotech's history was $2.5M.
See more information about OneThree Biotech